Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
BNF presentation directory
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
- Product: Lenalidomide
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Lenalidomide 25mg capsules
0802040Y0AAADAD
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | 1 |
|
Lenalidomide 10mg capsules
0802040Y0AAABAB
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 15mg capsules
0802040Y0AAACAC
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 2.5mg capsules
0802040Y0AAAEAE
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 20mg capsules
0802040Y0AAAGAG
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 5mg capsules
0802040Y0AAAAAA
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
|
Lenalidomide 7.5mg capsules
0802040Y0AAAFAF
|
Lenalidomide | Lenalidomide | Malignant Disease and Immunosuppression | No data available |
Why monitor BNF codes?
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Understand demand drivers
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.